Coronary artery disease in women

References

• Elveback LR, Connolly DC, Melton LJ 3d. Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982. Mayo Clin Proc 1986:61(11):896–900
   PubMed Web of Science ®Google Scholar
• Eaker ED, Packard B, Thorn TJ. Epidemiology and risk factors for coronary heart disease in women. Cardiovasc Clin 1989: 19(3): 129–45
   PubMedGoogle Scholar
• Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986: 111(2):383–90
   PubMed Web of Science ®Google Scholar
• Tofler GH, Stone PH, Midler JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987:9(3):473–82
   PubMed Web of Science ®Google Scholar
• Dittrich H, Gilpin E, Nicod P, et al. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988:62(1):1–7
   PubMed Web of Science ®Google Scholar
• Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction: biology or methodology? JAMA 1990:263(8): 1092–6
   PubMed Web of Science ®Google Scholar
• Greenland P, Reicher-Reiss H, Goldbourt U, et al. In-hospital and 1-year mortality in 1,524 women after myocardial infarction: comparison with 4,315 men. Circulation 1991:83(2):484–91
   PubMed Web of Science ®Google Scholar
• Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991: 325(4):221–5
   PubMed Web of Science ®Google Scholar
• Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease: survival and ventricular enlargement investigators. N Engl J Med 1991:325(4):226–30
   PubMed Web of Science ®Google Scholar
• Hilts PJ. NIH starts women's health office. New York Times 1990 Sep 11: C9
   Google Scholar
• Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991: 265(14):1861–7
   PubMed Web of Science ®Google Scholar
• Tikkanen MJ, Nikkila EA, Kuusi T, et al. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J Clin Endocrinol Metab 1982:54(6): 1113–7
   PubMed Web of Science ®Google Scholar
• Bush TL, Miller VT. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. In: Mishell DR Jr, ed. Menopause: physiology and pharmacology. St Louis: Mosby-Year Book, 1987:187–208
   Google Scholar
• Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989:321 (10):641–6
   PubMed Web of Science ®Google Scholar
• Stadel BV. Oral contraceptives and cardiovascular disease. 1. N Engl J Med 1981:305(11): 612–8
   PubMed Web of Science ®Google Scholar
• Cramer DW, Cann CI. Risks and benefits of oral contraceptive use in women over 35. Maturitas 1988:Suppl 1:99–109
   Google Scholar
• Notelovitz M, Feldman EB, Gillespy M, et al. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial. Am J Obstet Gynecol 1989:160(5 Pt 2):1269–80
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 1989:321 (19): 1311–6
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989:79(1):8–15
   PubMed Web of Science ®Google Scholar
• Hong MK, Romm PA, Reagon K, et al. Total cholesterol/HDL ratio is the best predictor of anatomic coronary artery disease in women. (Abstr) J Am Coll Cardiol 1991: 17(2):389A
   Google Scholar
• Centers for Disease Control. Tobacco use by adults: United States, 1987. MMWR 1989: 38(40):685–7
   PubMedGoogle Scholar
• Shopland DR. The health consequences of smoking: cardiovascular disease: a report of the Surgeon General. Washington, DC: US Gov Print Off, 1983: DHHS publication No.(PHS)84–50204
   Google Scholar
• Fielding JE. Smoking: health effects and control. 1. N Engl J Med 1985:313(8):491–8
   PubMed Web of Science ®Google Scholar
• Burkman RT. Obesity, stress, and smoking: their role as cardiovascular risk factors in women. Am J Obstet Gynecol 1988: 158(6 Pt 2): 1592–7
   PubMed Web of Science ®Google Scholar
• Johansson S, Vedin A, Wilhelmsson C. Myocardial infarction in women. Epidemiol Rev 1983:5:67–95
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Kaufman DW, Helmrich SP, et al. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 1985:253(20):2965–9
   PubMed Web of Science ®Google Scholar
• Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 1983: 117(6):651–8
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Slone D, Rosenberg L, et al. Cigarette smoking and age at natural menopause. Am J Public Health 1980:70(4):420–2
   PubMed Web of Science ®Google Scholar
• Baron JA. Smoking and estrogen-related disease. Am J Epidemiol 1984: 119(1):9–22
   PubMed Web of Science ®Google Scholar
• Khaw KT, Tazuke S, Barrett-Connor E Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988: 318(26):1705–9
   PubMed Web of Science ®Google Scholar
• Shapiro S, Slone D, Rosenberg L, et al. Oral-contraceptive use in relation to myocardial infarction. Lancet 1979:1(8119):743–7
   PubMed Web of Science ®Google Scholar
• Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983:67(5):968–77
   PubMed Web of Science ®Google Scholar
• Kaufmann RL, Assal JP, Soeldner JS, et al. Plasma lipid levels in diabetic children: effect of diet restricted in cholesterol and saturated fats. Diabetes 1975:24(7):672–9
   PubMed Web of Science ®Google Scholar
• Kaplan NM, Lieberman E. Clinical hypertension. 3d ed. Baltimore: Williams & Wilkins, 1982:3, 28–9
   Google Scholar
• Shapiro AP, Rutan GH. Hypertension in women: differences and implications. In: Eaker ED, Packard B, Wenger NK, et al, eds. Coronary heart disease in women: proceedings of an NIH workshop. New York: Haymarket Dovma, 1987: 172–6
   Google Scholar
• Bush TL, Criqui MN, Cowan I D, et al. Cardiovascular disease mortality in women: results from the Lipid Research Clinics Follow-up Study. In: Eaker et al, eds,35 106–11
   Google Scholar
• Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988:37(12): 1595–607
   PubMed Web of Science ®Google Scholar
• Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 1985:110(5): 1100–7
   PubMed Web of Science ®Google Scholar
• Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1974:23(2): 105–11
   PubMed Web of Science ®Google Scholar
• Perlman JA, Wolf PH, Ray R, et al. Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of northern California women. Am J Obstet Gynecol 1988: 158(6 Pt 2): 1568–74
   PubMed Web of Science ®Google Scholar
• Waiden CE, Knopp RH, Wahl PW, et al. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984:311 (15):953–9
   PubMed Web of Science ®Google Scholar
• Kannel WB, Castelli WP, Gordon T, et al. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 1971:74(1): 1–12
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Miller DR, Kaufman DW, et al. Myocardial infarction in women under 50 years of age. JAMA 1983: 250(20):2801–6
   PubMed Web of Science ®Google Scholar
• Haynes SG, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol 1980:111(1):37–58
   PubMed Web of Science ®Google Scholar
• Eaker ED, Haynes SG, Feinleib M. Spouse behavior and coronary heart disease in men: prospective results from the Framingham Heart Study. II. Modification of risk in type A husbands according to the social and psychological status of their wives. Am J Epidemiol 1983: 118(1):23–41
   PubMed Web of Science ®Google Scholar
• Slaby AR. Cardiovascular risk factors in women by their working status. Presented before 22d Conference on Cardiovascular Disease Epidemiology. San Antonio, TX: 1983 Mar 5–6
   Google Scholar
• Jacobsen BK, Thelle DS. Risk factors for coronary heart disease and level of education: the Troms Heart Study. Am J Epidemiol 1988: 127(5):923–32
   PubMed Web of Science ®Google Scholar
• Liu K, Cedres LB, Stamler J, et al. Relationship of education to major risk factors and death from coronary heart disease, cardiovascular diseases and all causes: findings of three Chicago epidemiologic studies. Circulation 1982:66(6): 1308–14
   PubMed Web of Science ®Google Scholar
• Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J 1989:117(5): 1177–88
   PubMed Web of Science ®Google Scholar
• Wenger NK. Coronary disease in women. Annu Rev Med 1985:36:285–94
   PubMed Web of Science ®Google Scholar
• Kannel WB, Abbott RD. Incidence and prognosis of myocardial infarction in women: the Framingham study. In: Eaker et al, eds,” 208–14
   Google Scholar
• Tofler GH, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987:9(3):473–82
   PubMed Web of Science ®Google Scholar
• Lapidus L. Ischaemic heart disease, stroke and total mortality in women: results from a prospective population study in Gothenburg, Sweden. Acta Med Scand Suppl 1985:705:1–42
   PubMedGoogle Scholar
• Kimmelstiel C, Goldberg R, Becker R, et al. Impact of female gender on incidence and prognosis of infarction-associated heart failure: the Worchester Heart Attack Trial. (Abstr) J Am Coll Cardiol 1990:15(2):168A
   Google Scholar
• Stone PH, Muller JE, Hartwell T, et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis: the MILIS Study Group. J Am Coll Cardiol 1989: 14(1):49–57
   PubMed Web of Science ®Google Scholar
• Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985:8(3):230–4
   PubMed Web of Science ®Google Scholar
• Opie LH, Tansey MJ, Kennelly BM. The heart in diabetes mellitus. II. Acute myocardial infarction and diabetes. S Afr Med J 1979:56(7): 256–60
   PubMed Web of Science ®Google Scholar
• Greaves M, Preston FE. Hemostatis abnormalities in diabetes. In: Jarrett RJ, ed. Metabolic aspects of cardiovascular disease. 2. Diabetes and heart disease. New York: Elsevier Science Publishing, 1984:47–80
   Google Scholar
• Guiteras VP, Chaitman BR, Waters DD, et al. Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women. Circulation 1982:65(7): 1465–74
   PubMed Web of Science ®Google Scholar
• Sketch MH, Mohiuddin SM, Lynch JD, et al. Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms. Am J Cardiol 1975:36(2): 169–73.
   PubMed Web of Science ®Google Scholar
• Gibson RS, Beller GA. Should exercise electrocardiographic testing be replaced by radioisotope methods? In: Rahimtoola SH, ed. Controversies in coronary arteny disease. Philadelphia: FA Davis, 1983:1–31
   Google Scholar
• Taillerfer R. New myocardial perfusion imaging agents and imaging protocols in the 1990s. In: Course syllabus, cardiovascular nuclear medicine. Cincinnati: Society of Nuclear Medicine, 1991: Jun: 1–23
   Google Scholar
• Melin JA, Wijns W, Vanbutsele RJ, et al. Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. Circulation 1985:71(3):535–42
   PubMed Web of Science ®Google Scholar
• Rifkin RD, Parisi AF, Folland E. Coronary calcification in the diagnosis of coronary artery disease. Am J Cardiol 1979:44(1): 141–7
   PubMed Web of Science ®Google Scholar
• Hung J, Chaitman BR, Lam J, et al. Noninvasive diagnostic test choiccs for the evaluation of coronary artery disease in women: a multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy. J Am Coll Cardiol 1984:4(1):8–16
   PubMed Web of Science ®Google Scholar
• Okada RD, Boucher CA, Strauss HW, et al. Exercise radionuclide imaging approaches to coronary artery disease. Am J Cardiol 1980:46(7): 1188–204
   PubMedGoogle Scholar
• Hanley PC, Zinsmeister AR, Clements IP, et al. Gender-related differences in cardiac response to supine exercise assessed by radionuclide angiography. J Am Coll Cardiol 1989:13(3):624–9
   PubMed Web of Science ®Google Scholar
• Sawada SG, Ryan T, Fineberg NS, et al. Exercise echocardiographic detection of coronary artery disease in women. J Am Coll Cardiol 1989: 14(6):1440–7
   PubMed Web of Science ®Google Scholar
• Nguyen T, Beer S, Heo J, et al. Detection of coronary artery disease in women. (Abstr) J Am Coll Cardiol 1991;17(2):77A
   Google Scholar
• The Aspirin Myocardial Infarction Study Research Group. The Aspirin Myocardial Infarction Study: final results. Circulation 1980:62 (Suppl V):79–84
   Google Scholar
• Golding LR, Groves LK. Results of coronary artery surgery in women. Cleve Clin Q 1976:43(3):113–5, 176
   PubMedGoogle Scholar
• Cosgrove DM, Loop FD, Lyde BW, et al. Primary myocardial revascularization: trends in surgical mortality. J Thorac Cardiovasc Surg 1984:88(5 Pt 1):673–84
   PubMed Web of Science ®Google Scholar
• Fisher LD, Kennedy JW, Davis KB, et al. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 1982:84(3):334–41
   PubMed Web of Science ®Google Scholar
• Khan SS, Nessim S, Gray R, et al. Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med 1990:112(8):561–7
   PubMed Web of Science ®Google Scholar
• Cowley MJ, Mullin SM, Kelsey SF, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation 1985:71 (1):90–7
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984: 53(12):77–81C
   PubMed Web of Science ®Google Scholar
• Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989:321(3): 129–35
   PubMed Web of Science ®Google Scholar
• Manson JE, Stampfer MJ, Colditz GA, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991: 266(4):521–7
   PubMed Web of Science ®Google Scholar
• The Expert Panel. Repon of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988:148(1):36–69
   PubMedGoogle Scholar
• Lissner L, Odell PM, D'Agostino RB, et al. Variability of body weight and health outcomes in the Framingham population. N Engl J Med 1991: 324(26): 1839–44
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991: 324(23): 1619–25
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N Engl J Med 1991:325(11):756–62
   PubMed Web of Science ®Google Scholar
• Colditz GA, Stampfer MJ, Willett WC, et al. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990:264(20):2648–53 [erratum, JAMA 1991;265 (14): 1828]
   PubMed Web of Science ®Google Scholar